ArticleCancer drug resistance (Alhambra, Calif.)2020

Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma.

Alicia Martínez-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.